Physician profile
Dawn Wilson
NPI 1346237187
$1,001.97
in general payments reported to CMS, 2019-2025
16 companies · $69.29 in 2025
The $69.29 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $22.86 · 2021: $48.80 · 2022: $167 · 2023: $179 · 2024: $415 · 2025: $69.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $222.09 | 2022-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.15 | 2022-2024 | Xifaxan |
| Comsort, INC | $100.00 | 2019 | |
| Lilly USA, LLC | $86.54 | 2024 | Omvoh |
| Abbvie INC. | $83.49 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $81.27 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $75.95 | 2022-2024 | Ocaliva |
| Janssen Biotech, INC. | $51.10 | 2023-2024 | Stelara, Simponi Aria, Remicade |
| Merck Sharp & Dohme LLC | $43.03 | 2022-2023 | Dificid, Zinplava |
| Acacia Pharma INC | $36.15 | 2021 | |
| Horizon Therapeutics Plc | $22.86 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $22.10 | 2024 | Iqirvo |
| Fresenius Kabi USA, LLC | $15.65 | 2023 | Idacio |
| Evoke Pharma, INC. | $13.12 | 2022 | |
| Vivus LLC | $12.65 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyaire Medical, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.